RARRES2 and colitis: To determine the impact of increased circulating bioactive chemerin levels on the development and/or progression of DSS-induced colitis, we injected 6- to 8-week-old WT mice with bioactive chemerin (aa17–156) or PBS control every other day throughout DSS treatment starting on day 0.